Produktinformation
- (5Z)-5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidinedione Sodium Salt Hydrate
Applications GSK 1059615 is a potent inhibitor of PI 3-kinase α (PI3Kα). GSK 1059615 inhibits proliferation in BT474 cells and attenuates MAPK signaling.
References Saadia, et al.: Clin. Cancer Res., 15, 3029 (2009), Knight, et al.: ACS Med. Chem. Lett., 1, 39 (2010),